Your browser doesn't support javascript.
loading
Lenalidomide improves the antitumor activity of CAR-T cells directed toward the intracellular Wilms Tumor 1 antigen.
Zhang, Li; Jin, Guangyi; Chen, Ziren; Yu, Changhua; Li, Yonghui; Li, Yisheng; Chen, Jinghong; Yu, Li.
Afiliação
  • Zhang L; Department of Hematology and Oncology, International Cancer Center, Shenzhen Key Laboratory, Shenzhen University General Hospital, Shenzhen, Guangdong, People's Republic of China.
  • Jin G; Department of Hematology and Oncology, International Cancer Center, Shenzhen Key Laboratory, Shenzhen University General Hospital, Shenzhen, Guangdong, People's Republic of China.
  • Chen Z; Department of Hematology and Oncology, International Cancer Center, Shenzhen Key Laboratory, Shenzhen University General Hospital, Shenzhen, Guangdong, People's Republic of China.
  • Yu C; Department of Hematology and Oncology, International Cancer Center, Shenzhen Key Laboratory, Shenzhen University General Hospital, Shenzhen, Guangdong, People's Republic of China.
  • Li Y; Central Laboratory, Shenzhen University General Hospital, Shenzhen, People's Republic of China.
  • Li Y; Department of Hematology and Oncology, International Cancer Center, Shenzhen Key Laboratory, Shenzhen University General Hospital, Shenzhen, Guangdong, People's Republic of China.
  • Chen J; Department of Hematology and Oncology, International Cancer Center, Shenzhen Key Laboratory, Shenzhen University General Hospital, Shenzhen, Guangdong, People's Republic of China.
  • Yu L; Department of Hematology and Oncology, International Cancer Center, Shenzhen Key Laboratory, Shenzhen University General Hospital, Shenzhen, Guangdong, People's Republic of China.
Hematology ; 26(1): 818-826, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34674611
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Neoplasias Hematológicas / Proteínas WT1 / Lenalidomida / Fatores Imunológicos Limite: Animals / Humans Idioma: En Revista: Hematology Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Neoplasias Hematológicas / Proteínas WT1 / Lenalidomida / Fatores Imunológicos Limite: Animals / Humans Idioma: En Revista: Hematology Assunto da revista: HEMATOLOGIA Ano de publicação: 2021 Tipo de documento: Article